Exousia Bio, Inc. (LMMY) › Operating Cash FlowExousia Bio, Inc. (LMMY) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2023: -$38.1K2024: -$12.5K2025: -$4.5K-$4.5K2023Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$4.5K+63.7%2024-$12.5K+67.2%2023-$38.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share